Group One Trading’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Sell
599,600
-396,400
-40% -$1.25M ﹤0.01% 2248
2025
Q4
$3.69M Buy
996,000
+634,100
+175% +$2.05M 0.01% 1763
2025
Q3
$959K Buy
361,900
+311,000
+611% +$602K ﹤0.01% 3076
2025
Q2
$50.1K Sell
50,900
-51,200
-50% -$51.3K ﹤0.01% 5573
2025
Q1
$147K Sell
102,100
-244,300
-71% -$450K ﹤0.01% 4269
2024
Q4
$762K Buy
346,400
+169,500
+96% +$395K ﹤0.01% 2811
2024
Q3
$292K Sell
176,900
-100,700
-36% -$203K ﹤0.01% 3287
2024
Q2
$616K Sell
277,600
-115,600
-29% -$272K ﹤0.01% 2374
2024
Q1
$1.05M Sell
393,200
-211,700
-35% -$514K ﹤0.01% 2036
2023
Q4
$1.81M Buy
604,900
+349,100
+136% +$453K ﹤0.01% 1957
2023
Q3
$251K Buy
255,800
+69,800
+38% +$101K ﹤0.01% 3609
2023
Q2
$259K Sell
186,000
-240,400
-56% -$336K ﹤0.01% 3673
2023
Q1
$678K Sell
426,400
-367,600
-46% -$1.9M ﹤0.01% 2479
2022
Q4
$4.95M Buy
794,000
+73,800
+10% +$528K 0.01% 1154
2022
Q3
$4.83M Buy
720,200
+10,700
+2% +$73.5K 0.01% 1188
2022
Q2
$4.51M Buy
709,500
+216,600
+44% +$1.23M 0.01% 1373
2022
Q1
$2.29M Buy
492,900
+26,400
+6% +$113K ﹤0.01% 2269
2021
Q4
$2.33M Buy
466,500
+390,500
+514% +$3.13M ﹤0.01% 2430
2021
Q3
$916K Buy
76,000
+26,900
+55% +$392K ﹤0.01% 3513
2021
Q2
$1.04M Sell
49,100
-29,800
-38% -$718K ﹤0.01% 3371
2021
Q1
$2.21M Buy
78,900
+18,400
+30% +$543K ﹤0.01% 2362
2020
Q4
$1.57M Buy
60,500
+26,600
+78% +$797K ﹤0.01% 2247
2020
Q3
$1.26M Buy
33,900
+4,100
+14% +$162K ﹤0.01% 1988
2020
Q2
$1.53M Sell
29,800
-12,900
-30% -$540K 0.01% 1666
2020
Q1
$1.35M Buy
42,700
+14,000
+49% +$739K 0.01% 1302
2019
Q4
$1.71M Buy
28,700
+16,500
+135% +$742K 0.01% 1416
2019
Q3
$447K Buy
12,200
+5,000
+69% +$198K ﹤0.01% 2426
2019
Q2
$335K Buy
7,200
+1,000
+16% +$47K ﹤0.01% 2495
2019
Q1
$249K Sell
6,200
-59,800
-91% -$2.68M ﹤0.01% 2541
2018
Q4
$3.04M Buy
66,000
+41,000
+164% +$1.98M 0.03% 765
2018
Q3
$1.11M Buy
25,000
+1,100
+5% +$50.5K 0.01% 1625
2018
Q2
$937K Sell
23,900
-43,700
-65% -$2.21M 0.01% 1785
2018
Q1
$4.89M Buy
67,600
+46,800
+225% +$3.44M 0.05% 487
2017
Q4
$1.37M Sell
20,800
-200
-1% -$10.8K 0.01% 1456
2017
Q3
$1.05M Sell
21,000
-35,600
-63% -$1.72M 0.01% 1527
2017
Q2
$2.62M Buy
56,600
+33,900
+149% +$1.25M 0.03% 795
2017
Q1
$802K Buy
22,700
+22,600
+22,600% +$518K 0.01% 1494
2016
Q4
$1K Sell
100
-63,200
-100% -$753K ﹤0.01% 4305
2016
Q3
$877K Buy
63,300
+61,700
+3,856% +$699K 0.01% 1366
2016
Q2
$16K Buy
1,600
+1,500
+1,500% +$24.9K ﹤0.01% 3891
2016
Q1
$2K Sell
100
-29,400
-100% -$473K ﹤0.01% 4366
2015
Q4
$657K Sell
29,500
-60,400
-67% -$1.52M 0.01% 1601
2015
Q3
$2.12M Buy
89,900
+53,900
+150% +$3.38M 0.03% 747
2015
Q2
$2.94M Buy
36,000
+26,000
+260% +$2.55M 0.04% 543
2015
Q1
$926K Buy
10,000
+700
+8% +$45.2K 0.01% 1144
2014
Q4
$376K Buy
+9,300
New +$285K 0.01% 1781

Other funds holding ESPR